Biotech & healthcare
AI compresses R&D cycles
Ranked by momentum (2)
| # | Entity | Kind | Momentum | Divergence | 30d |
|---|---|---|---|---|---|
| 1 | google-deepmind/alphafold3 | repo | 47 | — | |
| 2 | chaidiscovery/chai-lab | repo | 38 | — |
Public bench
Public names carry no momentum — their signal class is filings + quarterly fundamentals.
| Company | Latest filing | Capex (Q) | Revenue (Q) | 8q capex |
|---|---|---|---|---|
| $RXRX Recursion Pharmaceuticals | 8-K 2026-06-18 · sec.gov | $258k▼-86% | $6.5M▲+25% | |
| $TEM Tempus AI | 8-K 2026-05-22 · sec.gov | $8.2M▲+295% | $348.1M▲+4% |
Cascade — private → public
- ↳ category beneficiary$TEMTempus AIcapex $8.2M▲+295%· 8-K 2026-05-22Open bio-models accelerate precision-medicine data platforms.
- ↳ category beneficiary$RXRXRecursion Pharmaceuticalscapex $258k▼-86%· 8-K 2026-06-18Structure-prediction progress compounds AI-first drug-discovery platforms.
Recent events
No recent events for this theme.